Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

60 results about "Cysteamine" patented technology

This medication is used to help preserve kidney function and manage kidney damage and other problems in people with an inherited disorder that causes build-up of a certain natural substance (cystine) in the body (nephropathic cystinosis).

Modified castor oil-based polyurethane adhesive as well as preparation method and application thereof

The invention relates to the technical field of organic polymer adhesives, and particularly discloses a modified castor oil-based polyurethane adhesive as well as a preparation method and application thereof. The adhesive comprises two components, and the component A comprises the following components in parts by weight: 30.0-50.0 parts of modified castor oil and 0.0-30.0 parts of refined castor oil; the component B is prepared from the following components in parts by weight: 30.0 to 50.0 parts of polyisocyanate or a polyisocyanate modifier and 0.00 to 0.05 part of a dewatering agent; the modified castor oil is prepared from refined castor oil and cysteamine through a sulfydryl-alkene addition reaction. Amido of the modified castor oil is alkalescent, and the reaction speed of the modified castor oil and isocyanate groups is high; hydrogen bonds are easily generated between urea bonds generated by the reaction of amino groups and isocyanate groups, so that the adhesive is endowed with thixotropy and high strength. The adhesive disclosed by the invention is simple in composition, high in reaction speed and good in thixotropy and bonding strength.
Owner:YANTAI RUILONG CHEM TECH CO LTD

Low-temperature anti-oxidation conductive copper paste, preparation method and RFID tag

The invention discloses low-temperature anti-oxidation conductive copper paste, a preparation method and an RFID tag, and relates to the field of conductive paste. The modified copper powder comprises: copper powder; the cysteamine self-assembly molecular layer is formed by coupling sulfydryl of cysteamine with the surface of the copper powder; the metal phthalocyanine complex molecular layer is coordinated with central metal ions of metal phthalocyanine molecules through amino groups of cysteamine and is connected to the surface of the cysteamine self-assembled molecular layer; and the conductive copper paste is sintered at 140-170 DEG C. According to the low-temperature curing conductive copper paste, the problem of anti-oxidation defects of the copper powder can be effectively solved while the conductivity of the copper powder is ensured, and the low-temperature curing conductive copper paste with long-acting anti-oxidation performance and high conductivity is obtained.
Owner:CANGNAN ANTE SECURITY TECH

Preparation method and application of cystamine modified hyaluronic acid hydrogel

The invention provides a preparation method and application of cystamine modified hyaluronic acid hydrogel. The preparation method comprises the step of synthesizing hydrogel with a three-dimensional network structure by taking hyaluronic acid as a carrier and cystamine as a cross-linking agent. The insoluble drug is entrapped by the hydrogel, so that the solubility of the insoluble drug is effectively improved. The preparation method disclosed by the invention is simple in process, the prepared hydrogel has excellent performance and has the characteristics of uniform pores, good hydrophilicity, high drug loading capacity and high encapsulation efficiency, and the prepared drug-loaded hydrogel can slowly and continuously release drugs and has good antioxidant and antibacterial properties.
Owner:YANCHENG TEACHERS UNIV

Epoxy resin material for electronic plastic package of radio frequency chip and preparation method of epoxy resin material

The invention discloses an epoxy resin material for electronic plastic package of a radio frequency chip and a preparation method of the epoxy resin material. The preparation method comprises the following steps: firstly, carrying out alkylation reaction on dicyclopentadiene and phenol in the presence of a catalyst boron trifluoride diethyl etherate to synthesize dicyclopentadiene phenol resin, and epoxidizing the dicyclopentadiene phenol resin through epoxy chloropropane to obtain dicyclopentadiene epoxy resin DCPDDE; then, synthesizing a poly (dicyclopentadiene) linear polymer PDCPD by taking a Pd / Ag ionic compound as a catalyst, and then reacting the PDCPD with cysteamine sulfydryl to obtain dicyclopentadiene cysteamine PDCPDAm; and finally, mixing the DCPDDE, the PDCPDAm, the filler and the coupling agent, stirring, defoaming and curing to form the thermosetting resin with a three-dimensional network structure. The synthetic process is simple, the cost is low, the mobility and polarizability of molecules are limited due to high rigidity and low polarity of the obtained resin, transmission of a radio frequency chip under a high-frequency high-speed signal is ensured, stable operation in a complex working environment is ensured, reliable packaging protection is provided for the radio frequency chip, and the service life of the radio frequency chip is prolonged. And the thermal stability and the low dielectric property of the radio frequency chip are improved to the greatest extent.
Owner:JIANGSU UNIV

Preparation and application of gold electrode and electrochemical detection device

The invention discloses preparation and application of a gold electrode and an electrochemical detection device. The preparation method of the modified gold electrode comprises the following steps: activating a polished and ground bare gold electrode with nitric acid, and immersing the polished and ground bare gold electrode into a deoxidized cysteamine (Cyst) solution for 2 hours; washing with double distilled water and soaking for about 12 hours, and removing physically adsorbed Cyst to obtain a Cyst modified gold electrode; immersing the Cyst modified gold electrode into a nanogold solution for 18 hours, taking out and airing to obtain a colloidal gold-Cyst modified gold electrode; and finally, immersing the colloidal gold-Cyst modified gold electrode into Cyst for 2 hours, taking out and airing to obtain the target modified gold electrode. The modified gold electrode prepared by the method, a platinum wire electrode and a silver-silver chloride electrode form a three-electrode system. The modified gold electrode in the three-electrode system has a good electrochemical catalytic oxidation function on the uric acid, the peak current and the content of the uric acid are in a linear relation, and the system can be directly used for detecting the uric acid in the urine.
Owner:NANTONG INST OF TECH

Bimodal sensor and preparation method and application thereof

The invention discloses a bimodal sensor and a preparation method and application thereof. The bimodal sensor comprises functionalized nanogold, wherein the functionalized nanogold comprises nanogold; the surface of the nanogold is modified with 4-mercaptobenzoic acid and thymine; the thymine is modified by cysteamine. The functionalized nanogold can realize specific recognition of mercury ions in matrixes such as food and drugs, so that output of a colorimetric / surface enhanced Raman spectrum dual-mode detection result is realized, the purpose of self-correction detection is achieved, the selectivity, accuracy and efficiency of detection are improved, and the detection cost is reduced. The method can be applied to detection of mercury ions in natural environment, food, medicines and cosmetics.
Owner:KUNMING UNIV OF SCI & TECH

Formulations and methods for inhibiting environmental cracking

An environmental cracking inhibitor includes a base corrosion inhibitor and a sulfur compound modifier. The base corrosion inhibitor can be an imidazoline, an amine, a quaternary amine, a fatty acid derivative, a phosphate ester, or combinations thereof. The sulfur compound modifier can have the general formula HS—X, where X is a heteroatom substituted alkyl, cycloalkyl, aryl, and / or alkylaryl group. Suitable heteroatoms are sulfur, oxygen, phosphorus, nitrogen, and combinations thereof. The sulfur compound modifier can be 2 mercaptoethanol, cysteamine, or a cysteamine salt.
Owner:BAKER HUGHES OILFIELD OPERATIONS LLC

Method to produce organosulfur compounds using genetically modified microorganisms

PCT designated stageWO2026011241A1BacteriaHydrolasesTaurine synthesisCysteamine
Methods for producing organosulfur compounds from a prokaryotic cell comprising enzymes involved in the production of cysteamine, hypotaurine, and taurine. Said prokaryote may comprise a vanin selected from vanin-1 (vnn-1), vanin-2 (vnn-2), or vanin- 3 (vnn-3), a cysteamine dioxygenase (ado), and / or a flavin-containing monooxygenase 1 (fmo1). Methods include the expression of organosulfur compounds in Corynebacterium glutamicum with incubation conditions to promote compound production.
Owner:CHEM EVOLUTION LTD

An in vitro maturation medium for oocytes of hamsters and a preparation method thereof

This invention discloses an in vitro maturation culture medium for ferret oocytes and its preparation method, belonging to the field of animal embryo engineering technology. It comprises the following components: TCM199 basal culture medium, 50 mL fetal bovine serum, 25 IU follicle-stimulating hormone, 25 IU luteinizing hormone, 0.5 mg 17β-estradiol, 0.005 mg epidermal growth factor, 12.1 mg sodium pyruvate, 0.2 mM cysteine, 0.1 mM cysteine, 0.030 g penicillin, 0.025 g streptomycin sulfate, as well as an antioxidant complex, a combination of growth factors, and extracellular matrix components. This invention provides a comprehensive and suitable nutritional environment for ferret oocytes by precisely formulating a composite culture medium containing multiple key components. Specifically, the hormone combination at specific concentrations accurately simulates the in vivo physiological environment, effectively regulating the oocyte maturation process; multiple growth factors work synergistically to promote oocyte growth, development, and differentiation; and the addition of the antioxidant complex effectively eliminates free radicals generated during in vitro culture, reducing oxidative stress damage to oocytes.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

Gold nanoparticle array with strong stability and reusability and preparation and application thereof

ActiveCN116148340BStrong detection sensitivityOrderly and tightly arrangedLaser desorption ionization mass spectrometryCysteamine
The application relates to a gold nanoparticle array preparation method with strong stability and reusability, high cysteamine-stabilized gold nanoparticles are prepared first, the spacing between the gold nanoparticles is changed by utilizing the coulomb repulsion between the gold nanoparticles, then the gold nanoparticle solution is added dropwise to a glass surface modified by gamma-glycidoxypropyltrimethoxysilane to react, stable covalent bonds are formed, and gold nanoparticle arrays with uniform distribution on the glass surface can be obtained after the reaction. The preparation does not require high temperature, the experimental operation is simple and convenient, the gold nanoparticles are arranged in order and closely, have high detection sensitivity, have strong ultraviolet absorption capacity, good stability, reusability, salt resistance and low background interference, and can be reused. The gold nanoparticle array can realize detection analysis on high-salt-content samples in surface-assisted laser desorption ionization mass spectrometry and be used for rapid analysis of small molecule compounds in positive and negative ion dual modes.
Owner:SHANTOU UNIV

Hair-deforming cosmetic composition

To provide a hair-deforming cosmetic composition exhibiting low hair damage and having either a curling effect or a hair-straightening effect.SOLUTION: A hair-deforming cosmetic composition comprises thioglycolic acid, cysteamine, and an organic acid having a pKa value higher than that of thioglycolic acid, and its pH is adjusted to 8.0 or lower with a basic amino acid.SELECTED DRAWING: None
Owner:株式会社SSA

Methods for the treatment of cysteamine sensitive disorders

PendingEP4534527A3Powder deliverySugar derivativesCysteamineCystinosis
The invention features methods for the treatment of cystinosis and other cysteamine sensitive disorders in a subject including administration of a disulfide convertible to cysteamine in vivo. The methods can include the separate administration of a reducing agent to the subject to increase the bioavailablity and extend the plasma pharmacokinetic profile of the cysteamine produced following administration of the disulfide. The methods permit sustained cysteamine plasma concentrations in a subject.
Owner:THIOGENESIS THERAPEUTICS INC

Improved taurine biosynthesis using genetically modified bacteria

PCT designated stageWO2026011242A1BacteriaHydrolasesTaurine synthesisCysteamine
A genetically modified prokaryotic cell to express enzymes involved in the production of taurine. Said prokaryote comprises a vanin selected from: vanin- 1 (vnn-1), vanin-2 (vnn-2), or vanin- 3 (vnn-3), a cysteamine dioxygenase (ado), and a flavin-containing monooxygenase 1 (fmol), in addition to either the addition, alteration, or deletion of at least one gene involved in taurine synthesis or transport.
Owner:CHEM EVOLUTION LTD

A bimetallic copper-palladium nanoscale enzyme and a preparation method and application thereof

ActiveCN117340237BCysteamineTreatment effect
The present application relates to a kind of bimetallic copper palladium nanoscale enzyme and its preparation method and application, the bimetallic copper palladium nanoscale enzyme surface is decorated with cysteamine.The bimetallic copper palladium nanoscale enzyme described in the present application can be enriched in tumor site by passive targeting, can be used as radiotherapy sensitizer to inhibit the radiotherapy resistance of tumor, and improve the treatment effect of radiotherapy.
Owner:SHENZHEN TECH UNIV

Colchicine Hydrogel Microneedle and Preparation Method Thereof

A preparation method of a colchicine (COL) hydrogel microneedle (MN) is provided, including the following steps: dissolving an acrylamide (AM), N,N′-bis(acryloyl) cysteamine (BACA), and Irgacure 2959 in ultrapure water to obtain a clear gel solution; pouring the clear gel solution into a polydimethylsiloxane (PDMS) mold, conducting low-speed centrifugation, and conducting an ultrasonic treatment to eliminate air bubbles; irradiating the PDMS mold under ultraviolet light, and air-drying in an oven to obtain a hydrogel MN; and adding a COL solution to the hydrogel MN, allowing swelling, air-drying, and demolding. The present disclosure overcomes the shortcoming that cross-linking points are unevenly distributed in the ordinary hydrogel MNs. The hydrogel MN prepared by the present disclosure has a complete needle shape, a neat matrix arrangement, cross-linking points evenly distributed in a network, and excellent mechanical toughness and a superior swelling capacity.
Owner:ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE +1

Ophthalmic preparations and methods of use

The invention relates to ophthalmic compositions comprising thiol drugs, such as cysteamine, for the prevention and / or treatment of ocular conditions related to the hardening and / or opacification of the crystalline lens of the eye; for instance, ocular conditions such as cataracts and presbyopia.
Owner:BTV HLDG LLC

Synthesis method of cimetidine monocondensate and acetate thereof

The invention belongs to the technical field of organic synthesis. The invention particularly relates to a synthesis method of cimetidine monocondensate and acetate thereof. The method comprises the following steps: taking 1-halogenated butane-2, 3-diketone (compound 1) as a raw material, firstly carrying out substitution reaction with cysteamine and sodium hydroxide to generate 1-((2-aminoethyl) sulfenyl) butane-2, 3-diketone (compound 2), and then carrying out cyclization reaction with hexamethylenetetramine and ammonia gas to generate 2-(((4-methyl-1H-imidazole-5-yl) methyl) sulfenyl) ethylamine (cimetidine monocondensate). And carrying out post-treatment on the cimetidine monocondensate to obtain acetate of the 2-(((4-methyl-1H-imidazole-5-yl) methyl) sulfenyl) ethylamine. The method provided by the invention has the advantages of cheap and easily available materials, mild reaction conditions, high atom economy, relatively less three wastes, environmental friendliness, high product purity, product quality meeting subsequent requirements, and high yield.
Owner:HEBEI UNIV OF SCI & TECH

Method for determining cysteamine chelated zinc in premixed feed

The invention provides a method for determining cysteamine chelated zinc in premixed feed, and belongs to the technical field of analysis and detection. The invention provides a method for determining cysteamine chelated zinc in premixed feed, which comprises the following steps: preparing a cysteamine chelated zinc sample to obtain a near-infrared analysis and prediction sample set; performing first near-infrared analysis on the near-infrared analysis prediction sample set, and obtaining a calibration model according to obtained data; performing second near-infrared analysis on the premixed feed to obtain data of the sample to be detected; the premixed feed contains cysteamine chelated zinc; and obtaining the content of cysteamine chelated zinc in the premixed feed according to the data of the sample to be detected and the calibration model. The determination method provided by the invention has the advantages of no damage, high efficiency, low cost, environmental protection and accurate result.
Owner:BAIKANG BIOENGINEERING (SHENZHEN) CO LTD

Use of cysteamine and derivatives thereof to suppress tumor metastases

ActiveUS12667547B2CysteamineTumour metastasis
The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.
Owner:MESHABERASE LLC +1

Dosage regime

The present disclosure relates to use of cysteamine, formulations comprising cysteamine and pharmaceutically acceptable salts of cysteamine in the treatment of cystic fibrosis and conditions associated with cystic fibrosis.
Owner:NOVABIOTICS LTD

Skin depigmentation composition and use thereof

The present invention relates to a composition comprising cysteamine, azabenzene-4-carboxamide and glycolic acid. The present invention also relates to the cosmetic use thereof for inhibiting, reducing or preventing skin pigmentation and to the therapeutical use thereof for inhibiting, reducing or preventing skin hyperpigmentation diseases or disorders.
Owner:KASRAEE BEHROOZ

A disulfide cross-linked starch-based micelle and a preparation method and application thereof

The application discloses a kind of disulfide crosslinked starch-based micelles and its preparation method and application.The preparation method includes: using pullulanase to carry out branch removal treatment to waxy corn starch, and prepare dextrin;Using periodate on the dextrin is oxidized, and prepare dialdehyde dextrin;Make cysteamine and the dialdehyde dextrin grafting reaction, and prepare cysteamine-dextrin;The cysteamine-dextrin is dissolved in water and self-assembled to form micelles, then ultrasonic sulfhydryl oxidation is carried out, and prepare disulfide crosslinked starch-based micelles.The disulfide crosslinked starch-based micelles provided by the application with hydrophobic functional factor has higher hydrophobic functional factor loading and environmental stress stability, in vitro simulation release presents colon targeting, and has wide application prospect in the field of oral delivery of hydrophobic functional factor.
Owner:HEFEI UNIV OF TECH

Stable paper-based SERS (Surface Enhanced Raman Scattering) substrate as well as preparation method and application

PendingCN121556029AMaterial nanotechnologyTransportation and packagingCysteamineTetrabutylammonium nitrate
The invention discloses a stable paper-based SERS (Surface Enhanced Raman Scattering) substrate as well as a preparation method and application thereof, and belongs to the technical field of detection, filter paper is immersed into a KH-560 aqueous solution, dried at room temperature for 30-60 minutes and then immersed into a cysteamine aqueous solution, and thiol modified filter paper is obtained; agNPs sol, a tetrabutylammonium nitrate aqueous solution and dichloromethane are evenly mixed, AgNPs are arranged into a single layer on a water-gas interface, then cyclohexane is added, AgNPs are migrated to a water-cyclohexane interface, and a densely-stacked silver nanoparticle single layer is generated; after cyclohexane is removed, thiol modified filter paper is immersed below the silver nanoparticle single layer and then taken out to form the stable paper-based SERS substrate, and the stable paper-based SERS substrate is high in stability and reproducibility and can be used for rapid, accurate and trace detection of methylene blue in a water body.
Owner:SHAANXI UNIV OF SCI & TECH

Label-free quantum dot electrochemical luminescence sensing electrode for detecting mycotoxin as well as preparation method and application of label-free quantum dot electrochemical luminescence sensing electrode

The invention discloses an unmarked quantum dot electrochemical luminescence sensing electrode for detecting mycotoxin as well as a preparation method and application thereof. The preparation method comprises the following steps: preparing an interdigital electrode pair with two groups of independent detection channels on a glass substrate; self-assembling cysteamine on the surface of the gold working electrode to form an amination interface; sequentially carrying out covalent immobilization on the ZnCdS (at) ZnS quantum dots and different fungaltoxin aptamers through amidation reaction; and finally, sealing by using bovine serum albumin. The prepared sensing electrode has a unique complementary segmented interdigital structure, comb tooth parts of the gold working electrode and the platinum counter electrode are arranged in a staggered and non-contact manner, and annular parts are arranged in a concentric circle manner, so that electric field interference between channels is effectively avoided. The invention further provides application of the electrode, chemical labeling is not needed in the whole process of the method, high-sensitivity, high-specificity and parallel in-situ detection of high-harm mycotoxins such as ochratoxin A and zearalenone is achieved, the integration level is high, and the electrode is suitable for on-site rapid screening of food safety.
Owner:NINGBO UNIV

Formulations and methods for inhibiting environmental cracking

An environmental cracking inhibitor includes a base corrosion inhibitor and a sulfur compound modifier. The base corrosion inhibitor can be an imidazoline, an amine, a quaternary amine, a fatty acid derivative, a phosphate ester, or combinations thereof. The sulfur compound modifier can have the general formula (I). where X is a heteroatom substituted alkyl, cycloalkyl. aryl, and / or alkylaryl group. Suitable heteroatoms are sulfur, oxygen, phosphorus, nitrogen, and combinations thereof. The sulfur compound modifier can be 2 mercaptoethanol, cysteamine, or a cysteamine salt.
Owner:BAKER HUGHES OILFIELD OPERATIONS LLC

Preparation method and application of an alkaline degreasing agent

The present invention relates to the technical field of metal processing, and specifically to a preparation method and application of an alkaline degreasing agent. It includes the following steps: Step 1: First, cholesterol chloroformate and cysteamine undergo an ammonolysis reaction, then a click reaction with ethylene oxide, and finally polymerization is initiated to obtain surfactant A; Step 2: First, cholesterol chloroformate and bis(2-aminophenyl) disulfide undergo an ammonolysis reaction, and then an alcoholysis reaction with tea polyphenols to obtain surfactant B; Step 3: Prepare a chelating agent; formulate to obtain the alkaline degreasing agent. The alkaline degreasing agent includes the following components: The content of each component is: 5-15 g / L of sodium hydroxide, 10-20 g / L of sodium carbonate, 30-100 g / L of sodium phosphate, 5-7 g / L of sodium pyrophosphate, 2-5 g / L of sodium gluconate, 20-30 g / L of surfactant A, 10-20 g / L of surfactant B, 3-6 g / L of chelating agent, and the rest is deionized water.
Owner:JIANGSU HEHONG ELECTRONICS CO LTD

Agents, compositions and methods for enhanced delivery of nucleic acids to the cells within the respiratory system

PCT designated stage expiredWO2025101704A1Powder deliveryDispersion deliveryCysteamineSulfonate
The disclosure relates to compositions and methods for improving pulmonary delivery of therapeutic nucleic acids, e.g., DNA, mRNA, by enhancing transfection efficiency and thus efficacy of the therapeutic nucleic acids, using inhaled, Intranasal, Intratracheal, bronchial instillation and / or topical administration Intratracheal, bronchial instillation and / or topical administration transfection efficiency enhancing agents, including but not limited to 2-mercaptoethane sulfonate or cysteamine.
Owner:CILA THERAPEUTICS INC